167 tracked 13F filers disclose a position in CLOV as of the latest SEC 13F filings, a combined $220.9M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | $56.0M | 31.8M | ▼−1.4% Reduced · −440K sh | Q1 2026 | |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $29.9M | 17.0M | →First observed position No prior filed position | Q1 2026 | |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | $17.7M | 10.1M | ▲+2.7% Added · +264K sh | Q1 2026 | |
| 4 | STATE STREET CORP | $16.8M | 9.6M | ▲+2.6% Added · +240K sh | Q1 2026 | |
| 5 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9.3M | 5.3M | ▲+13% Added · +610K sh | Q1 2026 | |
| 6 | PNC FINANCIAL SERVICES GROUP, INC. | $6.6M | 3.8M | ▲~0% Added · +183 sh | Q1 2026 | |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | $6.5M | 3.7M | →First observed position No prior filed position | Q1 2026 | |
| 8 | DIMENSIONAL FUND ADVISORS LP | $6.0M | 3.4M | ▼−6.0% Reduced · −216K sh | Q1 2026 | |
| 9 | RENAISSANCE TECHNOLOGIES LLC | $6.0M | 3.4M | ▼−24% Reduced · −1.1M sh | Q1 2026 | |
| 10 | NORTHERN TRUST CORP | $5.8M | 3.3M | ▲+4.0% Added · +128K sh | Q1 2026 | |
| 11 | VANGUARD FIDUCIARY TRUST CO | $4.9M | 2.8M | →First observed position No prior filed position | Q1 2026 | |
| 12 | MORGAN STANLEY | $3.8M | 2.2M | ▼−16% Reduced · −413K sh | Q1 2026 | |
| 13 | GOLDMAN SACHS GROUP INC | $3.8M | 2.2M | ▲+22% Added · +384K sh | Q1 2026 | |
| 14 | CITADEL ADVISORS LLC | $3.3M | 1.9M | ▲+64% Added · +730K sh | Q1 2026 | |
| 15 | UBS Group AG | $3.1M | 1.8M | ▲+34% Added · +452K sh | Q1 2026 | |
| 16 | GMT CAPITAL CORP | $2.3M | 1.3M | ▲New +1.3M sh | Q1 2026 | |
| 17 | MILLENNIUM MANAGEMENT LLC | $2.1M | 1.2M | ▲New +1.2M sh | Q1 2026 | |
| 18 | Bank of New York Mellon Corp | $2.0M | 1.1M | ▼−3.0% Reduced · −35K sh | Q1 2026 | |
| 19 | JANE STREET GROUP, LLC | $1.8M | 1.0M | ▲+78% Added · +455K sh | Q1 2026 | |
| 20 | Nuveen, LLC | $1.6M | 936K | ▲+5.9% Added · +52K sh | Q1 2026 | |
| 21 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.6M | 899K | ▼−61% Reduced · −1.4M sh | Q1 2026 | |
| 22 | Swiss National Bank | $1.5M | 828K | —Held | Q1 2026 | |
| 23 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME | $1.2M | 682K | ▼−13% Reduced · −98K sh | Q1 2026 | |
| 24 | GROUP ONE TRADING LLC | $1.0M | 587K | ▼−46% Reduced · −501K sh | Q1 2026 | |
| 25 | Point72 Asset Management, L.P. | $885K | 503K | ▲New +503K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 6 funds opened a new position in CLOV and 18 added to an existing one, while 13 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| MICROSOFT CORPMSFT | 62 funds | $21.8B |
| AMAZON.COM INCAMZN | 62 funds | $17.8B |
| BROADCOM INCAVGO | 62 funds | $10.8B |
| ELI LILLY & COLLY | 62 funds | $7.0B |
| MICRON TECHNOLOGY INCMU | 62 funds | $4.8B |
| ADVANCED MICRO DEVICESAMD | 62 funds | $2.8B |
| BANK OF AMERICA CORPBAC | 62 funds | $2.5B |
| UNITEDHEALTH GROUP INCUNH | 62 funds | $2.5B |
| ALPHABET INC-CL AGOOGL | 61 funds | $14.5B |
| META PLATFORMS INC-CLASS AMETA | 61 funds | $10.9B |
| VISA INC-CLASS A SHARESV | 61 funds | $5.3B |
| COSTCO WHOLESALE CORPCOST | 61 funds | $4.8B |
Ranked by how many of CLOV's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 20, 2026 | Soares Karen | Chief Legal Officer | Sell (S) | 52K | $233K |
| Jul 17, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell (S) | 5K | $22K |
| Jul 15, 2026 | Soares Karen | Chief Legal Officer | Sell (S) | 11K | $49K |
| Jul 15, 2026 | Wai Conrad | CEO, Counterpart Health | Sell (S) | 24K | $113K |
| Jul 15, 2026 | Toy Andrew | Chief Executive Officer, Director | Sell (S) | 63K | $293K |
| Jul 15, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell (S) | 13K | $61K |
| Jul 15, 2026 | THORNTON JOSEPH CLAY | Interim CFO | Sell (S) | 5K | $22K |
| Jul 8, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell (S) | 2K | $11K |
| Jul 6, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell (S) | 6K | $33K |
| Jul 1, 2026 | Toy Andrew | Chief Executive Officer, Director | Sell (S) | 313K | $1.7M |
| Jun 17, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell (S) | 2K | $11K |
| Jun 16, 2026 | OLDAKOWSKI JOSEPH FRANK | VP OF FINANCE AND CONTROLLER | Sell (S) | 12K | $59K |
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/CLOV/capital-change-brief"
Use Arkolith's capital_change_brief for CLOV. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for CLOV. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.